Liposomes: A Highly Efficient and Reliable Nanocarrier For The Treatment Of Breast Cancer And Lung Cancer

Cancer is one of the diseases with the highest mortality rates in the world today, and cancer itself is very difficult to treat. Among these, breast cancer and lung cancer are exceptionally severe types of cancer. The complexity, heterogeneity, drug resistance, and immune evasion of cancer present enormous challenges for doctors and scientists. In recent decades, scientists have explored various methods to tackle cancer. Although progress has been made, treating cancer remains challenging. Using nanocarriers to deliver drugs for targeted therapy is an effective treatment method. However, nanoparticle-based drug therapies encounter issues such as targeting selectivity, biocompatibility, and safety concerns. Liposomes, a type of nanocarriers encased in lipid bilayers that encapsulate pharmaceuticals, exhibit their advantages among a plethora of carriers. Liposomes possess characteristics such as multiple targeting capabilities, high bioavailability, and elevated safety. At present, it has emerged as a nanocarrier for combating various cancers, including breast cancer and lung cancer. This article will focus on the characteristics of liposomes and their therapeutic efficacy in the treatment of lung cancer and breast cancer.